These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8224453)

  • 1. Tissue and plasma fibronectin level in patients with head and neck carcinoma.
    Baskin Y; Kirkali G; Güner G; Sengör T; Ceryan K
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):308S. PubMed ID: 8224453
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue and plasma elastase and anti-protease (alpha 1 protease inhibitor-alpha 2 macroglobulin) levels in malignancies of head and neck.
    Kirkali G; Baskin Y; Güner G; Sengör T; Ceryan K
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):307S. PubMed ID: 7693524
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasmatic fibronectin in malignancies.
    Gallurt P; Rodriguez P; Lorenzo A; López Saez JJ; Senra A; Millán J
    Int J Biol Markers; 1992; 7(4):240-3. PubMed ID: 1491180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical studies in head and neck cancer.
    Lal H
    Clin Biochem; 1994 Aug; 27(4):235-43. PubMed ID: 8001283
    [No Abstract]   [Full Text] [Related]  

  • 5. Tissue sialic acid and fibronectin levels in human prostatic cancer.
    Süer S; Sönmez H; Karaaslan I; Baloğlu H; Kökoğlu E
    Cancer Lett; 1996 Feb; 99(2):135-7. PubMed ID: 8616816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the extra domain B of fibronectin, a marker of angiogenesis, in head and neck tumors.
    Birchler MT; Milisavlijevic D; Pfaltz M; Neri D; Odermatt B; Schmid S; Stoeckli SJ
    Laryngoscope; 2003 Jul; 113(7):1231-7. PubMed ID: 12838025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cells as biomarkers of head and neck squamous cell carcinoma: an updated view.
    Mangano A; Mangano A; Lianos GD; Levrini L; Picone M; Boni L; Dionigi G
    Future Oncol; 2015; 11(13):1851-3. PubMed ID: 26161921
    [No Abstract]   [Full Text] [Related]  

  • 8. A Subcutaneous Tumour on the Posterior Neck: A Quiz.
    Omatsu J; Saigusa R; Miyagawa T; Numajiri H; Akamata K; Masui Y; Yamada D; Sato S
    Acta Derm Venereol; 2018 Aug; 98(8):817-819. PubMed ID: 29774367
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of survivin, carcinoembryonic antigen and ErbB2 level in oral squamous cell carcinoma patients.
    Li SX; Yang YQ; Jin LJ; Cai ZG; Sun Z
    Cancer Biomark; 2016; 17(4):377-382. PubMed ID: 27662323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podoplanin expression and its emerging role as a prognostic indicator in systemic tumors besides head and neck malignancies.
    Kapoor S
    J Surg Oncol; 2013 Mar; 107(4):446. PubMed ID: 22991299
    [No Abstract]   [Full Text] [Related]  

  • 11. Aggressive and recurrent desmoid-type fibromatosis of the neck.
    Monaco F; Monaco M; Barone M
    Asian Cardiovasc Thorac Ann; 2015 Oct; 23(8):1002. PubMed ID: 24696104
    [No Abstract]   [Full Text] [Related]  

  • 12. Macrophage colony-stimulating factor as a tumor marker for squamous cell carcinoma of the head and neck.
    Kuropkat C; Dünne AA; Plehn S; Ossendorf M; Herz U; Renz H; Werner JA
    Tumour Biol; 2003; 24(5):236-40. PubMed ID: 15001836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer.
    Nathan CO; Franklin S; Abreo FW; Nassar R; De Benedetti A; Glass J
    J Clin Oncol; 1999 Sep; 17(9):2909-14. PubMed ID: 10561370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.
    Rubin Grandis J; Melhem MF; Gooding WE; Day R; Holst VA; Wagener MM; Drenning SD; Tweardy DJ
    J Natl Cancer Inst; 1998 Jun; 90(11):824-32. PubMed ID: 9625170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma platelet-derived growth factor: preliminary study of a potential marker in head and neck cancer.
    Gleich LL; Srivastava L; Gluckman JL
    Ann Otol Rhinol Laryngol; 1996 Sep; 105(9):710-2. PubMed ID: 8800057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Birthday of a breakthrough: fibronectin research proves important, but not as originally expected.
    Longtin R
    J Natl Cancer Inst; 2004 Jan; 96(1):6-8. PubMed ID: 14709727
    [No Abstract]   [Full Text] [Related]  

  • 17. Elevated levels and fragmented nature of cellular fibronectin in the plasma of gastrointestinal and head and neck cancer patients.
    Warawdekar UM; Zingde SM; Iyer KS; Jagannath P; Mehta AR; Mehta NG
    Clin Chim Acta; 2006 Oct; 372(1-2):83-93. PubMed ID: 16730689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidermal growth factor (EGF) receptors in squamous cell carcinoma of the head and neck region].
    Lörz M; Bettinger R; Meyer-Breiting E
    Laryngorhinootologie; 1991 Aug; 70(8):438-40. PubMed ID: 1910383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical midline schwannoma.
    Piñeiro-Aguín Z; García-Lorenzo J; Simonetti S
    Acta Otorrinolaringol Esp; 2015; 66(4):234-6. PubMed ID: 24524799
    [No Abstract]   [Full Text] [Related]  

  • 20. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
    Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
    Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.